Facebook Linkedin RSS Twitter Youtube
Home 2023

REGENXBIO

A New-Wave Biosensor Approach for Direct, Fast, and High-Throughput AAV Process Development
Bioprocessing

A New-Wave Biosensor Approach for Direct, Fast, and High-Throughput AAV Process Development

Kathy Vuksanaj -
22
Gene Therapy Pioneers Share Genome Editing Insights at Chardan Conference
Drug Discovery

Gene Therapy Pioneers Share Genome Editing Insights at Chardan Conference

Alex Philippidis -
0
Dimension Therapeutics Spurns Regenxbio for Sweeter Ultragenyx Offer
Genome Editing

Dimension Therapeutics Spurns Regenxbio for Sweeter Ultragenyx Offer

GEN Staff Writer -
0
Ultragenyx Offers $138M for Dimension Therapeutics, as Bidding War with Regenxbio Looms
Genome Editing

Ultragenyx Offers $138M for Dimension Therapeutics, as Bidding War with Regenxbio Looms

GEN Staff Writer -
0
Regenxbio to Acquire Dimension Therapeutics
Genome Editing

Regenxbio to Acquire Dimension Therapeutics

GEN Staff Writer -
0
Voyager Exercises Options for Regenx Gene Therapy Vectors
Genome Editing

Voyager Exercises Options for Regenx Gene Therapy Vectors

GEN Staff Writer -
0
Biogen Licenses Regenxbio Vectors
Industry News

Biogen Licenses Regenxbio Vectors

GEN Staff Writer -
0
Newly Capitalized REGENXBIO Targets Gene Therapy Market
Genome Editing

Newly Capitalized REGENXBIO Targets Gene Therapy Market

GEN Staff Writer -
0
Voyager Licenses ReGenX’ NAV Vectors to Develop CNS Disease Gene Therapies
Genome Editing

Voyager Licenses ReGenX’ NAV Vectors to Develop CNS Disease Gene Therapies

GEN Staff Writer -
0
ReGenX, Esteve to Develop Sanfilippo Syndrome Treatments
Genome Editing

ReGenX, Esteve to Develop Sanfilippo Syndrome Treatments

GEN Staff Writer -
0
12Page 1 of 2
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.